Therapeutic mammoplasty: An advanced oncoplastic breast surgery technique

Dr Sanjit Agrawal - Tata Medical Center, Kolkata, India
Therapeutic mammoplasty: An advanced oncoplastic breast surgery technique ( Dr Sanjit Agrawal - Tata Medical Center, Kolkata, India )
16 Jul 2026

Defining breast cancer quality care around the globe

Dr Didier Verhoeven, Prof Sabine Siesling, Prof Pankaj Gupta Roy & Prof Cary Kaufman
Defining breast cancer quality care around the globe ( Dr Didier Verhoeven, Prof Sabine Siesling, Prof Pankaj Gupta Roy & Prof Cary Kaufman )
1 Jul 2026

Giredestrant plus palbociclib shows limited benefit in ER-positive, HER2-negative metastatic breast cancer

Dr Mabel Mardones - Rocky Mountain Cancer Centers, Denver, USA
Giredestrant plus palbociclib shows limited benefit in ER-positive, HER2-negative metastatic breast cancer ( Dr Mabel Mardones - Rocky Mountain Cancer Centers, Denver, USA )
10 Jun 2026

Sacituzumab govitecan improves PFS across Trop-2, BRCA, and HER2 metastatic triple-negative breast cancer

Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA
Sacituzumab govitecan improves PFS across Trop-2, BRCA, and HER2 metastatic triple-negative breast cancer ( Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA )
9 Jun 2026

Sacituzumab govitecan plus pembrolizumab improves PFS across biomarker subgroups in metastatic triple-negative breast cancer

Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA
Sacituzumab govitecan plus pembrolizumab improves PFS across biomarker subgroups in metastatic triple-negative breast cancer ( Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA )
9 Jun 2026

Gedatolisib combinations double PFS vs alpelisib in PIK3CA-mutant advanced breast cancer

Dr Sara Hurvitz - Fred Hutchinson Cancer Center, Seattle, USA
Gedatolisib combinations double PFS vs alpelisib in PIK3CA-mutant advanced breast cancer ( Dr Sara Hurvitz - Fred Hutchinson Cancer Center, Seattle, USA )
2 Jun 2026

Sacituzumab govitecan plus pembrolizumab improves outcomes beyond progression in PD-L1-positive mTNBC

Dr Kevin Kalinsky - Winship Cancer Institute, Atlanta, USA
Sacituzumab govitecan plus pembrolizumab improves outcomes beyond progression in PD-L1-positive mTNBC ( Dr Kevin Kalinsky - Winship Cancer Institute, Atlanta, USA )
2 Jun 2026

ASCO 2026: Highlights and analysis

Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada
ASCO 2026: Highlights and analysis ( Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada )
1 Jun 2026

GLP-1 therapy associated with reduced breast cancer risk

Dr Elizabeth McDonald - University of Pennsylvania, Philadelphia, USA
GLP-1 therapy associated with reduced breast cancer risk ( Dr Elizabeth McDonald - University of Pennsylvania, Philadelphia, USA )
1 Jun 2026

Gene expression test guided therapy in ER+/HER2- early breast cancer allows safe chemotherapy omission

Dr Robert Stein - University College London, London, UK
Gene expression test guided therapy in ER+/HER2- early breast cancer allows safe chemotherapy omission ( Dr Robert Stein - University College London, London, UK )
1 Jun 2026

Weight loss intervention improves quality of life in breast cancer survivors

Dr Jennifer Ligibel - Dana-Farber Cancer Institute, Boston, USA
Weight loss intervention improves quality of life in breast cancer survivors ( Dr Jennifer Ligibel - Dana-Farber Cancer Institute, Boston, USA )
1 Jun 2026

Yoga improves mood, fatigue, and insomnia in cancer survivors following treatment

Dr Karen Mustian - Wilmot Cancer Institute, Rochester, USA
Yoga improves mood, fatigue, and insomnia in cancer survivors following treatment ( Dr Karen Mustian - Wilmot Cancer Institute, Rochester, USA )
31 May 2026